Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ: CVKD · Real-Time Price · USD
13.47
-0.66 (-4.70%)
Oct 27, 2025, 2:01 PM EDT - Market open
Cadrenal Therapeutics Market Cap
Cadrenal Therapeutics has a market cap or net worth of $27.57 million as of October 27, 2025. Its market cap has increased by 116.19% in one year.
Market Cap
27.57M
Enterprise Value
23.36M
1-Year Change
116.19%
Ranking
Category
Stock Price
$13.47
Market Cap Chart
Since the IPO on January 20, 2023, Cadrenal Therapeutics's market cap has decreased from $58.17M to $27.57M, a decrease of -52.60%. That is a compound annual growth rate of -23.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 28.93M | 12.01% |
| Dec 31, 2024 | 25.83M | 168.05% |
| Dec 29, 2023 | 9.64M | -83.44% |
| Jan 20, 2023 | 58.17M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 746.26B |
| Johnson & Johnson | 456.66B |
| AbbVie | 402.09B |
| UnitedHealth Group | 329.94B |
| AstraZeneca | 258.15B |
| Novartis AG | 253.40B |
| Novo Nordisk | 236.24B |
| Abbott Laboratories | 220.52B |